SynthesisFrontiers in endocrinology2022

Cardiovascular Benefits With Favorable Renal, Amputation and Hypoglycemic Outcomes of SGLT-2 Inhibitors in Type 2 Diabetes From the Asian Perspective: A Population-Based Cohort Study and Systematic Review.

Chun-Ting Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.